Uncategorized

Richard Bentall and David Pilgrim offer their critique of genetic theories of schizophrenia for the Conversation. "The high heritability estimates reported in earlier quantitative...

For weeks I had been trying to get released from the psychiatric ward, and none of my arguments, compliance, or attempted air of normality had made an impression on the barely-visible ward psychiatrist. I had, I was told, made a very serious suicide attempt and this was a predictor of future attempts. They would let me know when they thought I was sufficiently remorseful and stabilized to be released.

The New England Journal of Medicine (NEJM) has come under intense scrutiny for delayed corrections and controversial editorials and articles. “The Journal and its...

After over thirty years in the mental health system and almost five institutionalized, Deena Hoblit continues to search for closure through the study of...

Dr. Jim van Os presents something unlike any other psychiatrist I have come across: a clear vision, and a pathway, for dismantling the existing mental health system and replacing it with something new that actually works. And he is doing it with all the status and prestige not only of a psychiatry insider, but as one of the world's leading scientists. Along with changes in the definitions of health and psychosis, van Os describes pilot programs now underway in The Netherlands to establish small, human-scale services — inspired by Open Dialogue — that engage the social network of people in distress. And, inspired by the best of the US "peer" movement, by involving people who have themselves recovered from madness in a treatment role.

The basic idea of the experiential democracy project is to supplement conventional legislative or other forms of diplomatic and moral deliberation with person-centered (“I-Thou”) principles of encounter. These principles, which derive from existential-humanistic psychology and person-centered therapy, stress the attempt to engage participants to more intimately understand each other, and through this context to more intimately understand each other’s often conflicting positions on issues of moral import.

I don't usually talk about this much because it's still somewhat traumatizing. I don't really do advocacy around shock treatment because it still triggers too much stuff. But this is a modern day advanced story of medical harms and misinformation, and you should comment on the FDA ruling.

Since the 1980s, antidepressant use has risen by at least four-hundred percent and obesity rates have climbed to include thirty percent of the population....

On February 22, Allen Frances, MD, published an article titled Psychiatry and Anti-Psychiatry on the HuffPost Blog.  The general theme of the article is that psychiatry may have some problems, but it is basically sound, wholesome, and necessary. The impression being conveyed here is that psychiatry's abandonment of a biopsychosocial approach and embracing of the brief med-check was the result of "drastic cuts in the funding of the mental health services." This is very misleading. The fact is that psychiatry set its own course when it jumped enthusiastically on the pharma bandwagon, and apart, from a miniscule minority who remained aloof from the drug-pushing, has made no attempt to alight.

As the benzodiazepine crisis spreads throughout the United States and other parts of the world, so does the debate within the benzo victim/survivor community. We know that it can be terribly invalidating to label and treat a person as a “drug addict” who is only physically dependent on benzos — and taking these drugs exactly as prescribed by a doctor. However, it can be equally invalidating to deny that “iatrogenic benzo dependence” intersects in multiple ways in the lives of people struggling with “addiction.” People will ALSO SUFFER when yanked off of their benzos, or forced into similar rapid tapers when a doctor becomes aware of their addiction history. 

Creating Community Solutions, part of the national mental health dialogue project, was started over four years ago to engage the public around mental health. It was based on a concept called deliberative democracy, where people who disagree with each other engage in dialogue to come to different solutions for a problem. However, for many reasons, this particular project only engaged with one part of the community. The chance to hear from the public was completely missed. Here is how that happened.

In the past five years, there has been a dramatic explosion of interest in the Open Dialogue Therapy practiced in Tornio, Finland. It is a humanistic “treatment” that has produced five-year outcomes for psychotic patients that are, by far, the best in the developed world, and there are now groups in the United States, Europe and beyond that are seeking to “import” this care. However, the challenges for doing so are many and, last month, Open Dialogue UK - on the occasion of the first-ever fully recognized Open Dialogue training outside of Tornio - organized a conference in London to hold an open dialogue about Open Dialogue.

Editors of even mainstream publications know that most of their readers hate TV drug ads, and so that’s why I could get the below piece published on AlterNet and then picked up by Salon. What’s most important to me in this piece—but which I did not “lede” with because I doubt that editors would have run it if I had is that: (1) Abilify was originally a drug for schizophrenia but has become a best-selling drug because it is now advertised as booster medication for antidepressants because antidepressants, as the Abilify commercial tells us, do not work for 2/3 of antidepressant users; and (2) Peter Gotzsche, in his book Deadly Medicines and Organized Crime, and Peter Rost, former vice president of marketing at Pfizer, equate Big Pharma with organized crime and the mob.

Dorrit Cato Christensen is an author, lecturer and chairman of the Danish association Dead in Psychiatric Care. She devoted her life to helping people...

Have you ever tried to do community engagement or join a coalition of people working on mental health stuff? If you have been unhappy doing coalition work or community engagement, they may have said it was you. They may have complained that you were too demanding or too triggered by your trauma issues. But the problem is not on us as advocates. This is a structural problem. How do you keep the disease model people from dominating?

When people are “mad,” they are often insisting that certain things are so, and frequently seem unwilling or incapable of appreciating or learning from other perspectives. Yet when the supposedly “sane” mental health system approaches those who are mad, it typically does the same thing – it insists that its own view of what’s going on is correct, and seems incapable of appreciating or learning from others, whether they be the patient, the family, former users of services, or anyone who understands madness in a different way.

On Tuesday, the FDA entered into a settlement agreement in Amarin Pharma v. U.S. Food & Drug Administration, allowing Amarin to promote a prescription drug for off-label use, so long as its promotion is truthful and non-misleading. The Amarin Settlement seems to be an abandonment by the federal government of protecting the public from off-label prescriptions.  But these settlement were just the cost of doing business for the drug companies, while they continue rake in huge profits from the continued off-label prescribing of drugs, which does not diminish after the settlements. Of course, anything that is false or misleading is still grounds for charges, but that is a far harder case to make. I think the ban against off-label promotion is dead for all practical purposes.  

First, let me tell you that I was once a typical doctor, not to mention a typical American who loved pizza, soda, birth control, and ibuprofen. I believed in the science that I was taught to believe in. I felt that medication was the answer. And that symptoms were problems that needed to be fixed, suppressed, eradicated. That every patient was just one chemical prescription away from functioning “normally.” It wasn’t until my fellowship specialized in medicating pregnant and breastfeeding women, at a time when I was also pregnant, that I began to feel into a voice inside me that said, “I’m writing prescriptions that no amount of reported ‘safety data’ could convince me to take."

The more acutely and tellingly psychiatry is criticized, the more adamantly it defends its concepts and practices. But it seldom addresses the actual criticisms, relying instead on spin and on the endless regurgitation of the same tired old assertions: "we're real doctors; we treat real illnesses; our treatments are effective; and we deserve more respect." I have personally heard physicians make negative comments about psychiatry, but these have always been directed against the widely-acknowledged invalidity of its 'diagnoses,' and the general lack of science in the development and assessment of its 'treatments.'

In this article I will attempt to debunk one of the great “scientific” smoke and mirrors shows of the past half century—the claim that stories of reunited separated MZ (monozygotic, identical) twin pairs indicate that heredity plays a major role in causing human behavioral differences. These stories, which are often used to sell the false ideology of genetic determinism, have entered the public imagination in a way that academic research results never could. Here I will show that these stories provide no evidence whatsoever that (as yet undiscovered) “genes for behavior” influence human behavioral development.

What is schizophrenia? According to the website of the National Institute of Mental Health (NIMH), schizophrenia is a chronic, severe, incurable, and disabling brain disorder that affects about 1% of Americans today. Its cause is unknown but most experts assume it is genetic. According to E. Fuller Torrey, the founder and Executive Director of the Stanley Medical Research Institute and a high-profile schizophrenia researcher, “schizophrenia is caused by changes in the brain and ... these can be measured by changes in both brain structure and brain function. … Schizophrenia is thus a disease of the brain in exactly the same sense that Parkinson’s disease, multiple sclerosis, epilepsy, and Alzheimer’s disease are diseases of the brain.” Behind this confident rhetoric lies a heated controversy.

Despite concerns about the risk to benefit ratio, the FDA approved flibanserin (Addyi) to treat low female sexual desire in August. In a new...

Anxiety is an awful reality. You feel a horrible paralyzing fear in the core of your chest or stomach, spreading to your arms and legs. The uneasiness gnaws away at you, or spreads into an overwhelming panic. It is paralyzing, and relief can’t come soon enough. However, the myth that anxiety is a biological disease is false. The reason there is no evidence that human problems come from neurotransmitters and genetic defects is because it’s not true.

Vermont Governor Shumlin recently suggested a change to state law that would accelerate the process under which a person could be forced to take antipsychotic drugs against her will. The House Human Services Committee reviewed this proposal and I was asked to testify. What follows are my comments.

Massachusetts Bill HD 4554 needs to gain sufficient state representative support by Tuesday, March 1, 2016. This bill will put restrictions on the prescribing of benzodiazepines and non-benzodiazepine sleep aids, and will require that all patients be informed of the potential dangers of these drugs, specifically the dangers of long-term use.